Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Government of the United States”

99 pharma patents match "The Government of the United States" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 99
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 99 pharmaceutical patents matching "The Government of the United States" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

99 results for “The Government of the United States” · 30,257 patents in full index Clear search

  1. US 12364745

    Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted

  2. US 12292441

    Recombinant Acinetobacter baumannii strain AB5075

    The Government of the United States, as represented by the Secretary of the Army · Granted May 6, 2025 · Expires May 1, 2045

    granted

  3. US 12186363

    Compositions and methods for dengue virus chimeric constructions in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted

  4. US 12152242

    CRISPR therapy

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted

  5. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted May 21, 2024 · Expires May 16, 2044

    granted

  6. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    The Government of the United States · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  7. US 11963959

    Inhibitors for coronavirus

    The Government of the United States, as represented by the Secretary of the Army · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  8. US 11959096

    Methods for selective inhibition of pluripotent stem cells

    The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  9. US 11884718

    Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  10. US 11878064

    Nanoparticle/peptide method of blocking potassium channels

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted

  11. US 11865111

    Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  12. US 11865172

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  13. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  14. US 11746335

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  15. US 11744834

    Metal-porphyrin complexes for the inactivation of the biological activity of opioids

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  16. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  17. US 11739137

    Single domain antibodies to SARS-CoV-2 nucleocapsid protein

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  18. US 11691992

    Oxaborole analogs and uses thereof

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  19. US 11617800

    Nanoparticle-enhanced activity of a potassium channel-blocking peptide

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  20. US 11583578

    Plasmodium falciparum recombinanr xiexumapoeozoite protein compositions and method for vaccine delivery

    The Government of the United States, as represented by the Secretary of the Army · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  21. US 11542320

    Nucleic acids encoding single domain antibodies to chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  22. US 11497803

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted

  23. US 11471528

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The Government of the United States of America as represented by the Secretary of the Department · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  24. US 11459308

    Broad spectrum inhibitors of filoviruses

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.